Molecular Partners AG (MOLN) Earnings Date & Reports
Molecular Partners AG is a clinical stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MOLN is expected to report earnings to fall 3.40% to -38 cents per share on March 12
Q4'25
Est.
$-0.39
Q3'25
Beat
by $0.08
Q2'25
Missed
by $0.18
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.33
The last earnings report on October 30 showed earnings per share of -40 cents, beating the estimate of -47 cents. With 879.00 shares outstanding, the current market capitalization sits at 164.41M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MOLN showed earnings on October 30, 2025. You can read more about the earnings report here.